Filings (90d)
0
Other insiders active in the same sector
No other insider has filed at Andrew Moin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Moin?
Andrew Moin is a corporate insider of SAB Biotherapeutics, Inc. (SABS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew Moin last file a Form 4?
The most recent primary Form 4 on record is dated 29 September 2025, one of 2 filings going back to 2025.
